Europe's medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to "unreliable" tests conducted by Indian contract research firm Micro Therapeutic Research Labs. The decision, announced by the European Medicines Agency (EMA) on its website, is the latest blow for India's drug-testing industry, which has run into a series of problems with international regulators in recent years. Nobody at the Chennai-based company was immediately available to comment. The EMA said European officials had ...
EU wants to supend 300 generic drugs tested by Indian co Micro Therapeutic
There is no evidence of harm or lack of effectiveness of the medicines
Reuters Last Updated at March 27, 2017 08:26 IST